查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1874013

肌酸酐测量市场

Creatinine Measurement Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

预计肌酸酐测量市场将从 2024 年的 5.577 亿美元成长到 2031 年的 9.8251 亿美元，2031 年至 2031 年的年复合成长率(CAGR) 为 8.4%。该市场的一个重要趋势预计将是肾功能即时检测的兴起。

肌酸酐测量市场分析

老年人群尤其容易患上慢性肾臟疾病。美国糖尿病协会2021年的一项研究表明，约有3,840万美国人（占总人口的11.6%）患有糖尿病，其中约30%的患者年龄在65岁及以上。糖尿病会显着增加肾衰竭的风险；美国国家肾臟基金会的一项研究估计，全球每年约有30%的糖尿病患者会发展为肾臟疾病。因此，老年人口的成长可能会在未来几年推动肌酸酐检测市场的发展。

肌酸酐测量市场概览

肌酸酐检测是一种用于评估肾功能和识别肾臟疾病的诊断方法。尿液中肌酸酐水平升高可能提示肾臟损伤或慢性肾臟病、急性肾损伤等疾病。市场扩张的主要驱动力是慢性肾臟病发病率的上升和老年人口的增长。然而，向新型生物标记的过渡可能会在预测期内阻碍市场成长。

肌酸酐测量市场的驱动因素和机会

慢性肾病发生率上升将有利于市场

根据美国国家肾臟基金会统计，慢性肾臟病（CKD）的全球盛行率正在上升，影响全球约10%的人口，每年有数百万人因缺乏足够的治疗而死亡。超过200万人接受透析或肾臟移植治疗，主要集中在五个已开发国家：美国、日本、德国、巴西和义大利，而这五个国家的人口总和仅占全球人口的12%。 2024年全球疾病负担研究报告指出，慢性肾臟病导致了全球15%的死亡。

鑑于慢性肾臟病盛行率不断上升，它已被公认为一项重大的全球健康挑战。美国肾臟病学会 (ASN) 指出，分子诊断技术的进步正在改善肾臟疾病患者的治疗管理。因此，慢性肾臟病发病率的上升，以及肌酸酐检测在评估肾臟健康方面的优势，预计将在预测期内提升对肌酸酐检测设备的需求。

发展中国家的新兴市场

发展中地区，特别是亚太地区，医疗保健产业的蓬勃发展为市场参与者带来了巨大的机会。这些地区庞大的患者群体推动了对先进诊断技术的需求。例如，印度人口占全球总人口的18%，却占全球肾臟疾病负担的约17%。此外，透析治疗数量的不断增加也显示肾臟疾病盛行率显着上升。全球疾病负担研究估计，光是中国就有1.195亿肾臟疾病患者。因此，肾臟疾病病例的快速成长，加上诊断检测能力的不足，预计将在2031年之前为市场创造丰厚的成长机会。

肌酸酐测量市场細項分析

对肌酸酐测量市场进行分析的关键细分市场包括污染物、技术和食品类型。

  • 市场分为试剂盒和试剂，其中试剂盒在 2023 年将占据更大的市场份额。
  • 按类型划分，市场分为酶法和 Jaffe 动力学法，其中酶法在 2023 年的市场份额领先。
  • 从样本类型来看，市场分为血液或血清和尿液，其中血液或血清产品在 2023 年占据主导地位。
  • 对于最终用户而言，市场分为医院、诊断实验室和其他实体，其中医院在 2023 年将引领市场。

肌酸酐测量市场的地理分析

肌酸酐测量市场报告的地理范围分为五个区域：北美、亚太、欧洲、中东和非洲以及南美和中美洲。

在北美，肌酸酐检测市场目前正经历显着成长。推动这一增长的因素包括：患有各种肾臟疾病的老年人口不断增加、透析治疗的有利报销政策、医疗保健支出不断增长、提供肌酸酐检测服务的医院和诊所数量不断增加，以及技术进步和主要市场参与者的存在。

此外，美国有利的报销政策进一步推动了市场成长，促进了手术过程中导尿管的使用。许多保险公司承保实验室服务，其中联邦医疗保险（Medicare）根据服务项目，透过医师收费标准（PFS）或临床实验室收费标准（CLFS）进行报销。此外，实验室也为其他政府计画（如医疗补助计画（Medicaid）、三军医疗保险（TRICARE）和联邦员工健康福利计画（FEHBP））以及商业保险计画的受益人提供服务。

肌酸酐测量市场报告范围

肌酸酐测量市场的最新发展

肌酸酐检测市场评估是基于从一手和二手研究中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。以下是该市场近期在创新、业务拓展和策略方面的一些发展动态：

  • 2022年11月1日，创新酶业宣布推出用于生产诊断试剂盒的原料，包括用于胆固醇、肌酸激酶、肌酸酐、游离脂肪酸、同型半胱氨酸、唾液酸和甘油三酯等多种检测试剂盒的酶，确保为可靠的实验提供高品质的产品。 （资料来源：创新酶业，新闻稿）
  • 2022年3月，Nova Biomedical在所有中欧国家推出了Nova Max Pro肌酸酐/eGFR检测系统，旨在透过在医院外的即时检测环境中改善肾臟疾病的筛检和早期发现，从而提升肾臟护理水平。 （来源：Nova Biomedical，新闻稿）

肌酸酐测量市场报告的覆盖范围和交付成果

这份题为《肌酸酐检测市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 全球、区域和国家层面所有关键细分市场的市场规模和预测。
  • 市场动态，包括驱动因素、限制因素和主要机会。
  • 肌酸酐检测市场趋势。
  • 详细的PEST和SWOT分析。
  • 分析关键市场趋势、全球和区域框架、主要参与者、法规和最新发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展。
  • 深入的公司概况。

目录

第一章：引言

第二章：肌酸酐检测市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：肌酸酐测定及市场概况

  • 概述
  • PEST分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 南美洲和中美洲
  • 专家意见

第五章：肌酸酐测定及主要市场动态

  • 市场驱动因素
    • 慢性肾臟疾病盛行率不断上升
    • 老年人口不断增加
  • 市场限制
    • 转向新型生物标记
  • 市场机会
    • 发展中国家的新兴市场
  • 未来趋势
    • 床边肾功能检测
  • 影响分析

第六章：肌酸酐检测市场及全球分析

  • 全球肌酸酐检测市场收入预测与分析
  • 全球肌酸酐检测市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：肌酸酐检测市场分析及产品分类

  • 概述
  • 肌酸酐检测市场收入份额（按产品划分）（2024 年和 2031 年）
  • 套件
  • 试剂

第八章：肌酸酐检测市场及类型

  • 概述
  • 肌酸酐检测市场（按类型划分），2024 年和 2031 年（%）
  • 酵素法
  • 贾菲动力学方法

第九章：肌酸酐检测市场及依样本类型划分

  • 概述
  • 肌酸酐检测市场（按样本类型划分），2024 年和 2031 年（%）
  • 血液或血清
  • 尿

第十章：肌酸酐检测市场分析及最终用户划分

  • 概述
  • 肌酸酐检测市场（按最终用户划分）（2024 年和 2031 年）
  • 医院
  • 诊断实验室
  • 其他的

第十一章：肌酸酐检测市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
      • 英国
    • 法国
    • 西班牙
    • 义大利
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第十二章：肌酸酐检测市场及产业概况

  • 概述
    • 肌酸酐测量市场参与者的最新动态

第十三章：肌酸酐检测市场及主要公司概况

  • Siemens Healthineers AG
  • Abbott
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Danaher
  • Cayman Chemical
  • Randox Laboratories Ltd
  • Fujifilm Wako Pure Chemical Corporation
  • Beijing Leadman Biochemical Co., Ltd.
  • Shanghai Fosun Pharmaceutical Group Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Beijing Jiuqiang Biotechnology Co., Ltd.
  • Diazyme Laboratories, Inc.
  • Dialab GmbH
  • Maccura Biotechnology Co.

第十四章：附录

简介目录
Product Code: TIPBT00002180

The Creatinine Measurement Market is anticipated to grow from US$ 557.70 million in 2024 to US$ 982.51 million by 2031, reflecting a compound annual growth rate (CAGR) of 8.4% during the period from 2031 to 2031. A significant trend in this market is expected to be the rise of point-of-care testing for renal function.

Analysis of the Creatinine Measurement Market

The elderly population is particularly susceptible to chronic kidney diseases. Research by the American Diabetes Association in 2021 indicated that around 38.4 million Americans, or 11.6% of the population, are affected by diabetes, with approximately 30% of these individuals being 65 years or older. Diabetes significantly increases the risk of kidney failure; a study from the National Kidney Foundation estimates that about 30% of diabetic patients globally develop kidney disease each year. Therefore, the growing elderly demographic is likely to drive the growth of the creatinine measurement market in the coming years.

Overview of the Creatinine Measurement Market

Creatinine measurement is a diagnostic method used to evaluate kidney function and identify kidney diseases. High levels of creatinine in urine can indicate kidney damage or conditions such as chronic kidney disease or acute kidney injury. The market's expansion is primarily driven by the rising incidence of chronic kidney diseases and the increasing elderly population. However, the transition towards new biomarkers may hinder market growth during the forecast period.

Drivers and Opportunities in the Creatinine Measurement Market

Rising Incidence of Chronic Kidney Diseases to Benefit the Market

According to the National Kidney Foundation, the global prevalence of chronic kidney disease (CKD) is on the rise, affecting about 10% of the world's population, with millions dying annually due to lack of access to adequate treatment. Over 2 million individuals receive treatment through dialysis or kidney transplants, primarily in five developed nations: the US, Japan, Germany, Brazil, and Italy, which together account for only 12% of the global population. The 2024 Global Burden of Disease study reported that chronic kidney diseases contribute to 15% of global mortality.

Given the increasing prevalence of chronic kidney diseases, it is recognized as a significant global health challenge. The American Society of Nephrology (ASN) notes that advancements in molecular diagnostics are improving management for patients with kidney disorders. Consequently, the rising incidence of chronic kidney diseases, along with the advantages of creatinine measurement in assessing kidney health, is expected to enhance the demand for creatinine measurement devices throughout the forecast period.

Emerging Markets in Developing Nations

The expanding healthcare sector in developing regions, particularly in Asia Pacific, presents substantial opportunities for market participants. The large patient population in these areas is driving the demand for advanced diagnostic technologies. For example, India, which comprises 18% of the global population, accounts for about 17% of the global burden of kidney diseases. Additionally, the increasing number of dialysis procedures indicates a significant rise in renal disease prevalence. Estimates from the Global Burden of Disease suggest that China alone has 119.5 million patients with renal diseases. Thus, the rapid increase in kidney disease cases, combined with the gap in diagnostic test availability, is expected to create lucrative growth opportunities for the market by 2031.

Segmentation Analysis of the Creatinine Measurement Market

Key segments contributing to the analysis of the creatinine measurement market include contaminants, technology, and food type.

  • The market is categorized into Kits and Reagents, with the Kits segment holding a larger share in 2023.
  • By type, the market is divided into the Enzymatic Method and Jaffe's Kinetic Method, with the enzymatic method segment leading in market share in 2023.
  • In terms of sample type, the market is segmented into Blood or Serum and Urine, with blood or serum products dominating in 2023.
  • For end users, the market is classified into hospitals, diagnostic laboratories, and other entities, with hospitals leading the market in 2023.

Geographical Analysis of the Creatinine Measurement Market

The geographical scope of the creatinine measurement market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

In North America, the creatinine measurement market is currently experiencing significant growth. Factors contributing to this growth include an increasing elderly population with various kidney diseases, favorable reimbursement policies for dialysis, rising healthcare expenditures, and a growing number of hospitals and clinics offering creatinine measurement services, along with technological advancements and the presence of key market players.

Moreover, the favorable reimbursement landscape in the US is further propelling market growth by enhancing the adoption of urinary catheters during surgical procedures. Many insurance providers cover laboratory services, with Medicare offering reimbursements through either the Physician Fee Schedule (PFS) or the Clinical Laboratory Fee Schedule (CLFS), depending on the service. Additionally, laboratories provide services to beneficiaries of other government programs such as Medicaid, TRICARE, and the Federal Employee Health Benefit Plan (FEHBP), as well as commercial plans.

Scope of the Creatinine Measurement Market Report

Recent Developments in the Creatinine Measurement Market

The creatinine measurement market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Below are some recent developments in the market regarding innovations, business expansions, and strategies:

  • On November 1, 2022, Creative Enzymes announced the launch of raw materials for manufacturing diagnostic kits, including enzymes for various assay kits such as cholesterol, creatine kinase, creatinine, free fatty acid, homocysteine, sialic acid, and triglyceride kits, ensuring high-quality products for reliable experiments. (Source: Creative Enzymes, Press Release)
  • In March 2022, Nova Biomedical introduced the Nova Max Pro Creatinine/eGFR Meter System across all CE countries, aimed at enhancing kidney care through improved screening and early detection of kidney disease in point-of-care settings outside hospitals. (Source: Nova Biomedical, Press Release)

Coverage and Deliverables of the Creatinine Measurement Market Report

The report titled "Creatinine Measurement Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key segments.
  • Market dynamics including drivers, restraints, and key opportunities.
  • Trends in the creatinine measurement market.
  • Detailed PEST and SWOT analysis.
  • Analysis of key market trends, global and regional frameworks, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • In-depth company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Creatinine Measurement Market and By Product
    • 1.3.2 Global Creatinine Measurement Market and By Type
    • 1.3.3 Global Creatinine Measurement Market and By Sample Type
    • 1.3.4 Global Creatinine Measurement Market and By End User
    • 1.3.5 Global Creatinine Measurement Market and By Geography

2. Creatinine Measurement Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Creatinine Measurement and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
    • 4.2.4 Middle East and Africa
    • 4.2.5 South and Central America
  • 4.3 Expert Opinion

5. Creatinine Measurement and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Kidney Disorders
    • 5.1.2 Growing Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shift Toward Novel Biomarkers
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Point-of-Care Renal Functioning Testing
  • 5.5 Impact Analysis

6. Creatinine Measurement Market and Global Analysis

  • 6.1 Global Creatinine Measurement Market Revenue Forecast And Analysis
  • 6.2 Global Creatinine Measurement Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Creatinine Measurement Market Analysis and By Product

  • 7.1 Overview
  • 7.2 Creatinine Measurement Market Revenue Share, by Product (2024 and 2031)
  • 7.3 Kits
    • 7.3.1 Overview
    • 7.3.2 Kits: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Reagents
    • 7.4.1 Overview
    • 7.4.2 Reagents: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)

8. Creatinine Measurement Market and By Type

  • 8.1 Overview
  • 8.2 Creatinine Measurement Market, by Type, 2024 and 2031 (%)
  • 8.3 Enzymatic Method
    • 8.3.1 Overview
    • 8.3.2 Enzymatic Method: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Jaffe’s Kinetic Method
    • 8.4.1 Overview
    • 8.4.2 Jaffe’s Kinetic Method: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)

9. Creatinine Measurement Market and By Sample Type

  • 9.1 Overview
  • 9.2 Creatinine Measurement Market, by Sample Type, 2024 and 2031 (%)
  • 9.3 Blood or Serum
    • 9.3.1 Overview
    • 9.3.2 Blood or Serum: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Urine
    • 9.4.1 Overview
    • 9.4.2 Urine: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)

10. Creatinine Measurement Market Analysis and By End User

  • 10.1 Overview
  • 10.2 Creatinine Measurement Market, by End User (2024 and 2031)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Creatinine Measurement Market, Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Diagnostic Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostic Laboratories: Creatinine Measurement Market, Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Creatinine Measurement Market, Revenue and Forecast to 2031 (US$ Million)

11. Creatinine Measurement Market and Geographic Analysis

  • 11.1 North America: Creatinine Measurement Market
    • 11.1.1 Overview
    • 11.1.2 North America: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
    • 11.1.3 North America: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.1.4 North America: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.1.5 North America: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.1.6 North America: Creatinine Measurement Market, by End User , 2024 and 2031 (USD Million)
    • 11.1.7 North America: Creatinine Measurement Market, by Country, 2024 and 2031 (%)
    • 11.1.8 US: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.1 US: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.2 US: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.1.8.3 US: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.1.8.4 US: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.1.8.5 US: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.1.9 Canada: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.1 Canada: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.2 Canada: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.1.9.3 Canada: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.1.9.4 Canada: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.1.9.5 Canada: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.1.10 Mexico: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.1 Mexico: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.2 Mexico: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.1.10.3 Mexico: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.1.10.4 Mexico: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.1.10.5 Mexico: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.2 Europe: Creatinine Measurement Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Creatinine Measurement Market - Revenue and Forecast to 2031 (USD Million)
    • 11.2.3 Europe: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.2.4 Europe: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.2.5 Europe: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.2.6 Europe: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.7 Europe: Creatinine Measurement Market, by Country, 2018 and 2031 (%)
    • 11.2.8 Germany: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.1 Germany: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.2 Germany: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.8.3 Germany: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.8.4 Germany: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.8.5 Germany: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.9 UK: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.1 UK: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.2 United Kingdom: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.9.3 United Kingdom: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.9.4 United Kingdom: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.9.5 United Kingdom: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.10 France: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.1 France: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.2 France: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.10.3 France: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.10.4 France: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.10.5 France: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.11 Spain: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.1 Spain: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.2 Spain: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.11.3 Spain: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.11.4 Spain: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.11.5 Spain: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.12 Italy: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.1 Italy: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.2 Italy: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.12.3 Italy: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.12.4 Italy: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.12.5 Italy: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.3 Asia Pacific: Creatinine Measurement Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Creatinine Measurement Market - Revenue and Forecast to 2031 (USD Million)
    • 11.3.3 Asia Pacific: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.3.4 Asia Pacific: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.3.5 Asia Pacific: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.3.6 Asia Pacific: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.7 Asia Pacific: Creatinine Measurement Market, by Country, 2018 and 2031 (%)
    • 11.3.8 China: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.1 China: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.2 China: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.8.3 China: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.8.4 China: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.8.5 China: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.9 Japan: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.1 Japan: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.2 Japan: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.9.3 Japan: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.9.4 Japan: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.9.5 Japan: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.10 India: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.1 India: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.2 India: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.10.3 India: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.10.4 India: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.10.5 India: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.11 South Korea: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.1 South Korea: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.2 South Korea: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.11.3 South Korea: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.11.4 South Korea: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.11.5 South Korea: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.12 Australia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.1 Australia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.2 Australia: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.12.3 Australia: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.12.4 Australia: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.12.5 Australia: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.4 Middle East and Africa: Creatinine Measurement Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Creatinine Measurement Market - Revenue and Forecast to 2031 (USD Million)
    • 11.4.3 Middle East and Africa: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.4.4 Middle East and Africa: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.4.5 Middle East and Africa: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.4.6 Middle East and Africa: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.7 Middle East and Africa: Creatinine Measurement Market Share by Country and 2024 and 2031, (%)
    • 11.4.8 Saudi Arabia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.1 Saudi Arabia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.2 Saudi Arabia: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.4.8.3 Saudi Arabia: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.8.4 Saudi Arabia: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.4.8.5 Saudi Arabia: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.9 UAE: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.1 UAE: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.2 UAE: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.4.9.3 UAE: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.9.4 UAE: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.4.9.5 UAE: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.10 South Africa: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
      • 11.4.10.1 South Africa: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.2 South Africa: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.4.10.3 South Africa: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.10.4 South Africa: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.4.10.5 South Africa: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.5 South and Central America: Creatinine Measurement Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Creatinine Measurement Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.5.3 South and Central America: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.5.4 South and Central America: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.5.5 South and Central America: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.5.6 South and Central America: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.7 South and Central America: Creatinine Measurement Market, by Country, 2018 and 2031 (%)
    • 11.5.8 Brazil: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.1 Brazil: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.2 Brazil: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.5.8.3 Brazil: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.8.4 Brazil: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.5.8.5 Brazil: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.9 Argentina: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.1 Argentina: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.2 Argentina: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.5.9.3 Argentina: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.9.4 Argentina: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.5.9.5 Argentina: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)

12. Creatinine Measurement Market and Industry Landscape

  • 12.1 Overview
    • 12.1.1 Recent Developments by Players in the Creatinine Measurement Market

13. Creatinine Measurement Market and Key Company Profiles

  • 13.1 Siemens Healthineers AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Abbott
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cayman Chemical
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Randox Laboratories Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Fujifilm Wako Pure Chemical Corporation
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Beijing Leadman Biochemical Co., Ltd.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Beijing Jiuqiang Biotechnology Co., Ltd.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Diazyme Laboratories, Inc.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Dialab GmbH
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Maccura Biotechnology Co.
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms